MXPA01003195A - Carbohydrate vaccines for viral diseases. - Google Patents

Carbohydrate vaccines for viral diseases.

Info

Publication number
MXPA01003195A
MXPA01003195A MXPA01003195A MXPA01003195A MXPA01003195A MX PA01003195 A MXPA01003195 A MX PA01003195A MX PA01003195 A MXPA01003195 A MX PA01003195A MX PA01003195 A MXPA01003195 A MX PA01003195A MX PA01003195 A MXPA01003195 A MX PA01003195A
Authority
MX
Mexico
Prior art keywords
viral diseases
carbohydrate vaccines
vaccines
carbohydrate
viral
Prior art date
Application number
MXPA01003195A
Other languages
Spanish (es)
Inventor
Paul J Maddon
Original Assignee
Progenics Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Progenics Pharm Inc filed Critical Progenics Pharm Inc
Publication of MXPA01003195A publication Critical patent/MXPA01003195A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/21—Retroviridae, e.g. equine infectious anemia virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6081—Albumin; Keyhole limpet haemocyanin [KLH]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
MXPA01003195A 1998-10-01 1999-10-01 Carbohydrate vaccines for viral diseases. MXPA01003195A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10265798P 1998-10-01 1998-10-01
PCT/US1999/023013 WO2000018432A1 (en) 1998-10-01 1999-10-01 Carbohydrate vaccines for viral diseases

Publications (1)

Publication Number Publication Date
MXPA01003195A true MXPA01003195A (en) 2003-07-14

Family

ID=22290988

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA01003195A MXPA01003195A (en) 1998-10-01 1999-10-01 Carbohydrate vaccines for viral diseases.

Country Status (6)

Country Link
EP (1) EP1117432A1 (en)
JP (1) JP2002525339A (en)
AU (1) AU6285899A (en)
CA (1) CA2346061A1 (en)
MX (1) MXPA01003195A (en)
WO (1) WO2000018432A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1572963A4 (en) * 2002-10-11 2007-08-22 Univ Maryland Biotech Inst Carbohydrate-based synthetic vaccines for hiv
DE102004053219B3 (en) 2004-11-04 2006-04-06 Leuze Electronic Gmbh & Co Kg Optical sensor for determining position of object in surveillance field has square matrix-type optical sensor and has transmitters shining beams of light onto object

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU603585B2 (en) * 1986-05-07 1990-11-22 Sloan-Kettering Institute For Cancer Research Vaccine for stimulating or enhancing production of antibodies directed against GM2
US5102663A (en) * 1988-10-18 1992-04-07 Sloan-Kettering Instutute For Cancer Research Vaccine for stimulating or enhancing production of antibodies against 9-O-acetyl GD3

Also Published As

Publication number Publication date
WO2000018432A1 (en) 2000-04-06
CA2346061A1 (en) 2000-04-06
JP2002525339A (en) 2002-08-13
AU6285899A (en) 2000-04-17
EP1117432A1 (en) 2001-07-25

Similar Documents

Publication Publication Date Title
ZA9811848B (en) Vaccine.
ZA984969B (en) Vaccine.
ZA988789B (en) Vaccine.
GB2337755B (en) Virus vaccine
ZA991307B (en) Antibodies against human CD40.
PL351486A1 (en) Prrsv vaccines
ZA993338B (en) Pharmaceutical formulations.
ZA200004956B (en) Vaccine composition.
GB9812613D0 (en) Vaccine
ZA992478B (en) Adjuvant-containing dna vaccines.
HUP0105392A3 (en) Enhanced vaccines
GB9822714D0 (en) Vaccines
HK1040488A1 (en) Pharmaceutical formulations.
MXPA02000958A (en) Strategy for carbohydrate based cancer vaccines.
PL344519A1 (en) Vaccine
MXPA01003195A (en) Carbohydrate vaccines for viral diseases.
MXPA01010701A (en) Vaccine.
MXPA01004778A (en) Contraceptive antibody vaccines.
ZA200006160B (en) Vaccine.
ZA99872B (en) Vaccine.
GB9807805D0 (en) Vaccine
GB9821821D0 (en) Schistomiasis vaccine
ZA987303B (en) Vaccine.
ZA996341B (en) Coccidiosis vaccines.
GB9929768D0 (en) P.e.c.s.